Paul Moodispaw, MD
Cardiovascular Disease · Dublin, OHNPI 1518074616
Payments from drug & device makers
Across 19 payments — averaging $20.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lantheus Medical Imaging, Inc.$160
- Boston Scientific$81
- Cardinal Health 200 LLC$51
- Abbott$17
- W. L. Gore & Associates, Inc.$16
- Siemens Medical Solutions USA, Inc.$16
- plus $44 from 3 others
What the payments were for
- Food & beverage$385100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lantheus Medical Imaging, Inc. | 7 | $160 |
| Boston Scientific | 3 | $81 |
| Cardinal Health 200 LLC | 3 | $51 |
| Abbott | 1 | $17 |
| W. L. Gore & Associates, Inc. | 1 | $16 |
| Siemens Medical Solutions USA, Inc. | 1 | $16 |
| EKOS Corporation | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
How this compares
$385 in reported general payments places this provider in the 25th percentile of 827 cardiovascular disease providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 113 | $103,633 |
| EntrestoSacubitril/Valsartan | 22 | $23,307 |
| FarxigaDapagliflozin Propanediol | 15 | $19,601 |
| Prasugrel Hcl | 12 | $1,804 |
| Metoprolol Succinate | 131 | $1,272 |
| Ranolazine ErRanolazine | 14 | $1,090 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 20 | $718 |
| Atorvastatin Calcium | 82 | $544 |
| Ezetimibe | 22 | $393 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 45 | $333 |
| Amiodarone Hcl | 16 | $294 |
| Amlodipine Besylate | 44 | $272 |
| Metoprolol Tartrate | 33 | $271 |
| Losartan Potassium | 45 | $241 |
| Carvedilol | 57 | $234 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Dublin
- Samir KapadiaCleveland$11.1M
- Steven NissenCleveland$5.3M
- Milind DesaiCleveland$5M
- Abraham LincoffCleveland$3.6M
- Carlos HubbardCleveland$3.1M
- Guilherme AttizzaniCleveland$2.8M
- Wai Hong TangCleveland$2.2M
- Bhola RamaMarion$2.1M
- Mazen HannaCleveland$1.6M
- Akber MohammedSpringfield$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.